Compare Jones Lang LaSalle Inc (JLL) vs Nuvalent Inc (NUVL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Jones Lang LaSalle Inc vs Nuvalent Inc — how do they compare? Jones Lang LaSalle Inc trades at $325.29 (market cap $15.12B), while Nuvalent Inc trades at $123.96 (market cap $9.81B). The key difference: Jones Lang LaSalle Inc is the larger of the two by market cap, and Nuvalent Inc is trading nearer its 52-week high, Jones Lang LaSalle Inc nearer its low. Which is the better fit depends on your goals.
| JLL | NUVL | |
|---|---|---|
Market Cap | $15.12B | $9.81B |
Sector | Real Estate | Technology |
52-Week High | $358.66 | $123.96 |
52-Week Low | $253.48 | $72.16 |
Enterprise Value | $18.66B | $8.52B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Jones Lang LaSalle Inc
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $70 billion for clients across diverse public and private real estate strategies.
Read more on JLL →About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →
